+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Impact of fluoroquinolone resistance in Gram-negative bloodstream infections on healthcare utilization



Impact of fluoroquinolone resistance in Gram-negative bloodstream infections on healthcare utilization



Clinical Microbiology and Infection 21(9): 843-849



There has been a concerning increase in fluoroquinolone resistance among Gram-negative bloodstream isolates. This retrospective cohort study examines the implications of fluoroquinolone resistance on use of healthcare resources in patients with Gram-negative bloodstream infections (BSI). Hospitalized adults with first episodes of community-onset Gram-negative BSI from 2010 to 2012 at Palmetto Health Hospitals in Columbia, SC, USA were identified. Multivariate linear regression was used to examine risk factors for prolonged hospital length of stay (HLOS) in survivors of Gram-negative BSI. Among 474 unique patients, 384 (81%) and 90 (19%) had BSI due to fluoroquinolone-susceptible (FQ-S) and fluoroquinolone non-susceptible (FQ-NS) Gram-negative bacilli, respectively. The FQ-NS bloodstream isolates, particularly Escherichia coli, were more likely than FQ-S isolates to be multi-drug resistant (56% versus 6%, p < 0.001). Compared with patients with BSI due to FQ-S bloodstream isolates, those with FQ-NS isolates were more likely to receive inappropriate empirical antimicrobial therapy (26% versus 3%, p < 0.001), have longer mean HLOS (11.6 versus 9.3 days, p 0.03) and treatment duration with intravenous antibiotics during hospitalization (9.1 versus 7.1 days, p 0.001), and use outpatient intravenous antibiotics at hospital discharge (15% versus 8%, p 0.05). After adjustments in the multivariate model, inappropriate empirical antimicrobial therapy was an independent risk factor for prolonged HLOS in survivors of Gram-negative BSI (parameter estimate 3.65 days, 95% CI 0.43-6.86). Multi-drug resistance among FQ-NS bloodstream isolates limits both empirical and definitive antimicrobial treatment options and poses excessive burdens on the healthcare system.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 058060367

Download citation: RISBibTeXText

PMID: 26003282

DOI: 10.1016/j.cmi.2015.05.013


Related references

Prediction of Fluoroquinolone Resistance in Gram-Negative Bacteria Causing Bloodstream Infections. Antimicrobial Agents and ChemoTherapy 60(4): 2265-2272, 2016

Impact of healthcare-associated acquisition on community-onset Gram-negative bloodstream infection: a population-based study: healthcare-associated Gram-negative BSI. European Journal of Clinical Microbiology and Infectious Diseases 31(6): 1163-1171, 2012

Healthcare-associated Gram-negative bloodstream infections: antibiotic resistance and predictors of mortality. Journal of Hospital Infection 94(4): 381-385, 2016

Risk factors for fluoroquinolone resistance in Gram-negative bacilli causing healthcare-acquired urinary tract infections. Journal of Hospital Infection 76(4): 324-327, 2010

Fluoroquinolone use and resistance of Gram-negative bacteria causing healthcare-associated infections at a university hospital in Taiwan from 2000 to 2008. Journal of Infection 64(6): 618-620, 2012

Bloodstream infections with gram-negative organisms and the impact of multidrug resistance in patients with hematological malignancies. Annals of Hematology 97(11): 2225-2234, 2018

Preventing healthcare-associated Gram-negative bloodstream infections. Journal of Hospital Infection 98(3): 225-227, 2018

Season, weather and predictors of healthcare-associated Gram-negative bloodstream infections: a case-only study. Journal of Hospital Infection 101(2): 134-141, 2019

Fluoroquinolone use and resistance of Gram-positive bacteria causing healthcare-associated infections. Journal of Antimicrobial ChemoTherapy 67(6): 1560-1562, 2012

The start of another infection prevention learning curve: reducing healthcare-associated Gram-negative bloodstream infections. Journal of Hospital Infection 97(3): 205-206, 2017

Bloodstream infections in a medical-surgical intensive care unit: incidence, aetiology, antimicrobial resistance patterns of Gram-positive and Gram-negative bacteria. Clinical Microbiology and Infection 15(10): 943-946, 2009

Response to The start of another infection prevention learning curve: reducing healthcare-associated Gram-negative bloodstream infections. Journal of Hospital Infection 99(4): 432-434, 2018

A clinical prediction rule for fluoroquinolone resistance in healthcare-acquired gram-negative urinary tract infection. Infection Control and Hospital Epidemiology 32(11): 1124-1126, 2011

Impact of healthcare-associated acquisition on community-onset Gram-negative bloodstream infection a population-based study. European Journal of Clinical Microbiology & Infectious Diseases 31(6): 1163-1171, 2012

Does Limiting Fluoroquinolone Use in the Treatment of Community-Acquired Infections Prevent Resistance Among Gram-Negative Rods?. Infectious Disease in Clinical Practice 11(5): 271-275, 2002